IMI2-2018-15-04
IMI2-2018-15-04
1 project · €10,999,316 total EU contribution (project-level) · 28 participating organizations · 11 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€10,999,316
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (11)
- France (3)
- US (3)
- CH (2)
- LU (2)
- Netherlands (2)
- AT (1)
- BE (1)
- NO (1)
- SE (1)
- UK (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- Leiden University Medical Center1 projects · NL
- BIOSCI CONSULTING BVBA1 projects · BE
- BLUEBIRD BIO INC.1 projects · US
- BII GMBH1 projects · DE
- BREAKTHROUGH T1D1 projects · US
- PEI1 projects · DE
- DYNAMIC42 GMBH1 projects · DE
- UT1 projects · DE
- ROCHE1 projects · CH
- Fraunhofer1 projects · DE
- INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA1 projects · LU
- INSTITUT SERVIER D'INNOVATION THERAPEUTIQUE1 projects · FR
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVAR · 853988 | H2020 | €10,999,316 | €691,165 | Details |